Analysis of ID8 s.c. tumors from TAX2-treated animals for microvascular density (CD31 IHC) indicated that TAX2 anti-tumor effects do not rely here on its anti-angiogenic properties (Figure 4a). The gene discussed is PECAM1; the disease is neoplasm.